SUSQUEHANNA INTERNATIONAL GROUP, LLP

Holdings History for Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)

Symbol: LPCN on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0%	-0%	$200,019	24,909	-21,852	-47%	$8.03	Q4 2025
30 Sep 2025		0%	+0%	$133,736	46,761	+742	+1.6%	$2.86	Q3 2025
30 Jun 2025		0%	+0%	$145,420	46,019	+7,039	+18%	$3.16	Q2 2025
31 Mar 2025		0%	+0%	$123,956	38,980	+13,975		$3.18	Q1 2025
31 Dec 2024		0%	0%	$122,024	25,005	-3	-0.01%	$4.88	Q4 2024
30 Sep 2024		0%	0%	$112,286	25,008	+7	+0.03%	$4.49	Q3 2024
30 Jun 2024		0%	-0%	$206,008	25,001	-34,666	-58%	$8.24	Q2 2024
31 Mar 2024		0%	+0%	$310,268	59,667	+3,066	+5.4%	$5.20	Q1 2024
31 Mar 2024	call		-0%	$0	0	-87,100	-100%	$9.00	Q1 2024
31 Dec 2023		0%	+0%	$156,219	56,601	+31,272	+123%	$2.76	Q4 2023
31 Dec 2023	call	0%	0%	$240,396	87,100	-100	-0.11%	$2.76	Q4 2023
30 Sep 2023		0%	+0%	$74,467	25,329	+14,335	+130%	$2.94	Q3 2023
30 Sep 2023	call	0%	0%	$256,368	87,200	0		$2.94	Q3 2023
30 Jun 2023		0%	+0%	$54,970	10,994	+10,994	NEW	$5.00	Q2 2023
30 Jun 2023	call	0%	+0%	$436,000	87,200	+87,200	NEW	$5.00	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.